RHUMBLINE ADVISERS - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 88 filers reported holding SURFACE ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q1 2022$122,000
-43.8%
41,388
-8.9%
0.00%
Q4 2021$217,000
-38.0%
45,443
-1.8%
0.00%
Q3 2021$350,000
+5.4%
46,288
+4.2%
0.00%
Q2 2021$332,000
+514.8%
44,438
+293.4%
0.00%
Q1 2019$54,00011,2970.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$22,297,0007.41%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,291,0000.67%
SummerHaven Investment Management, LLC 128,078$970,0000.57%
Parkman Healthcare Partners LLC 248,267$1,879,0000.48%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$379,0000.21%
C M BIDWELL & ASSOCIATES LTD 33,030$250,0000.17%
ARK Investment Management 4,618,354$34,961,0000.08%
Knights of Columbus Asset Advisors LLC 114,594$867,0000.08%
Orbimed Advisors 909,666$6,886,0000.08%
HighVista Strategies LLC 13,932$105,0000.07%
View complete list of SURFACE ONCOLOGY INC shareholders